EIF2AK3 and glioma: Further analysis indicated that S4 promotes calreticulin exposure and the release of HMGB1 and HSP70/90, thereby activating the PERK-eIF2α and IRE1α-XBP1 pathways and facilitating DAMP release linked to ICD in glioma cells through the ER stress pathway (87).